Henry_Drysdale_Dakin

Henry Drysdale Dakin

Henry Drysdale Dakin

British chemist (1880–1952)


Henry Drysdale Dakin FRS[1] (12 March 1880  10 February 1952) was an English chemist.[2]

Quick Facts Born, Died ...

He was born in London as the youngest of 8 children to a family of steel merchants from Leeds. As a school boy, he conducted water analysis with the Leeds City Analyst. He was taught chemistry by Julius B. Cohen at the University of Leeds, and then he worked with Albrecht Kossel on arginase at the University of Heidelberg. He joined Columbia University in 1905, working in the lab of Christian Herter. During his work on amino acids he obtained his PhD from Leeds.[3][4][5][6][7] In 1905, he was one of the first scientists to successfully synthesise adrenaline in the laboratory (see: History of catecholamine research).

In 1914 he went back to England to offer his service with the war effort. Due to a request for a chemist by Alexis Carrel to the Rockefeller Institute, Dakin joined Carrel in 1916 at a temporary hospital in Compiègne. There they developed the Carrel–Dakin method of wound treatments. This consisted of intermittently irrigating the wound with Dakin's solution, a dilute solution of sodium hypochlorite (the active ingredient in common liquid bleach products) and boric acid. In the process, he analyzed more than 200 candidate substances, and developed quantitative methods to evaluate their effectiveness for disinfection and wound healing. The solution is still widely used for that purpose, as of 2013.[8] The World War I era Rockefeller War Demonstration Hospital (United States Army Auxiliary Hospital No. 1) was created, in part, to promote the Carrel–Dakin method:[9]

"The war demonstration hospital of the Rockefeller Institute was planned as a school in which to teach military surgeons the principles of and art of applying the Carrel-Dakin treatment."

Photograpgh of a ward of the Rockefeller War Demonstration Hospital.

After he married the widow of Christian Herter in 1916, he worked in his private laboratory in Scarsdale, New York and had several close collaborations with other scientists. His main working fields were amino acids and enzymes. The extraction of amino acids from hydrolyzed peptides by butanol was invented by him. He also was interested in organic chemistry and synthesis, and devised the Dakin reaction and the Dakin–West reaction.

He died shortly after the death of his wife in early 1952.


References

  1. Hartley, Percival (1952). "Henry Drysdale Dakin. 1880-1952". Obituary Notices of Fellows of the Royal Society. 8 (21): 128–148. doi:10.1098/rsbm.1952.0009. JSTOR 768804. S2CID 178501241.
  2. Rezayat, C.; Widmann, W. D.; Hardy, M. A. (2006). "Henry Drysdale Dakin: More Than His Solution". Current Surgery. 63 (3): 194–196. doi:10.1016/j.cursur.2006.04.009. PMID 16757372.
  3. "Classic articles in colonic and rectal surgery. Henry Drysdale Dakin 1880-1952. On the use of certain antiseptic substances in the treatment of infected wounds". Diseases of the Colon and Rectum. 26 (5): 354–358. 1983. doi:10.1007/bf02561720. PMID 6360592. S2CID 72231184.
  4. Hawthorne Jr, R. M. (1983). "Henry Drysdale Dakin, biochemist (1880-1952): The option of obscurity". Perspectives in Biology and Medicine. 26 (4): 553–566. doi:10.1353/pbm.1983.0023. PMID 6353350. S2CID 44757448.
  5. Clarke, H. T. (1952). "Henry Drysdale Dakin, 1880-1952". The Journal of Biological Chemistry. 198 (2): 491–494. doi:10.1039/jr9520003319. PMID 12999763.
  6. Anon (1952). "Henry Drysdale Dakin". Lancet. 1 (6704): 426. doi:10.1016/s0140-6736(52)90046-9. PMID 14898761.
  7. Levine, Jeffrey M. (September 2013). "Dakin's Solution: Past, Present, and Future". Advances in Skin & Wound Care. 26 (9): 410–414. doi:10.1097/01.ASW.0000432051.59348.cd. PMID 23958873.

Share this article:

This article uses material from the Wikipedia article Henry_Drysdale_Dakin, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.